Neurocrine and Voyager enter an agreement to fund and develop gene therapy candidates for the treatment of severe neurological diseases.
Neurocrine agrees to pay up to $1.7bn in ... - Cure Parkinson's
Neurocrine agrees to pay up to $1.7bn in gene therapy collaboration
Written by
Farooqji
To view profiles and participate in discussions please or .
Read more about...
3 Replies
•
A very big bet.
they have taken calculated risk. they may have carried out risk analysis before throwing money into it
Not what you're looking for?
You may also like...
Gene therapy is underway!
https://parkinsonsnewstoday.com/2021/02/26/biogen-sangamo-partners-developing-novel-gene-therapies/
AAV-GAD Gene Therapy
Did anyone hear of AAV-GAD gene therapy? I have a chance to get into a phase 1/2 trial, but...
Replace or reorganize neurons
need to be reorganized. Via vibration
Where gene therapy assume we have a loss of Neurons that...
Follow up on Stem Cell therapy
not specifically treat any disease. They only administer stem cell therapy and let the stem cells...
Laser light therapy for Parkinsons disease
Who has experience with Light therapy with low intensity lasers in Parkinson in Europe?
I heard...